Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 9.80B | 9.92B | 6.84B | 5.48B | 4.16B | 2.79B |
Gross Profit | 3.45B | 4.20B | 2.63B | 2.57B | 1.96B | 1.38B |
EBITDA | -606.92M | 65.86M | 2.39B | 1.53B | 1.28B | 840.27M |
Net Income | -1.95B | -1.18B | 726.38M | 696.00M | 564.50M | 447.57M |
Balance Sheet | ||||||
Total Assets | 14.84B | 14.84B | 16.53B | 9.76B | 6.99B | 5.87B |
Cash, Cash Equivalents and Short-Term Investments | 2.05B | 2.05B | 4.46B | 3.53B | 1.85B | 2.06B |
Total Debt | 7.18B | 7.18B | 7.52B | 1.46B | 2.17B | 1.61B |
Total Liabilities | 8.65B | 8.65B | 8.68B | 2.31B | 2.77B | 2.10B |
Stockholders Equity | 6.17B | 6.17B | 7.76B | 7.34B | 3.92B | 3.51B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.15B | -341.72M | 317.54M | 245.84M | 108.53M |
Operating Cash Flow | 0.00 | 91.02M | 772.23M | 1.29B | 913.97M | 715.18M |
Investing Cash Flow | 0.00 | -1.68B | -5.37B | -1.36B | -1.12B | -1.62B |
Financing Cash Flow | 0.00 | -822.32M | 5.54B | 1.75B | -15.27M | 933.81M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥4.39B | 15.32 | ― | 13.96% | 200.83% | ||
72 Outperform | ¥10.49B | 10.12 | 4.66% | 2.42% | -4.63% | ||
58 Neutral | C$3.32B | 6.33 | -0.75% | 6.13% | -2.19% | -11.60% | |
54 Neutral | ¥2.28B | ― | ― | -22.04% | -8.72% | ||
46 Neutral | ¥2.40B | ― | ― | -12.25% | -142.67% | ||
45 Neutral | ¥5.05B | ― | 0.82% | -2.38% | -40.23% | ||
45 Neutral | ¥7.64B | ― | 5.38% | 6.34% | -367.82% |
MINKABU THE INFONOID INC. reported a challenging fiscal year ending March 31, 2025, with a significant net loss and a decrease in total assets and equity. Despite a 6.3% increase in net sales, the company faced substantial operating and ordinary profit losses, leading to a negative impact on shareholder equity and the decision not to issue dividends for the fiscal year. The company forecasts a reduction in net sales for the upcoming fiscal year but anticipates a positive EBITDA and net income, indicating potential recovery efforts.